
Anheuser-Busch InBev (ABI) | Financial Analysis & Statements
Anheuser-Busch InBev SA/NV | Large-cap | Consumer Defensive
Anheuser-Busch InBev SA/NV | Large-cap | Consumer Defensive
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
59.8B
Gross Profit
33.0B
55.25%
Operating Income
15.1B
25.35%
Net Income
7.4B
12.41%
EPS (Diluted)
€2.86
Balance Sheet Metrics
Total Assets
206.6B
Total Liabilities
117.9B
Shareholders Equity
88.7B
Debt to Equity
1.33
Cash Flow Metrics
Operating Cash Flow
21.7B
Free Cash Flow
11.2B
Revenue & Profitability Trend
Anheuser-Busch InBev Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 59.8B | 59.4B | 57.8B | 54.3B | 46.9B |
Cost of Goods Sold | 26.7B | 27.4B | 26.3B | 23.1B | 19.6B |
Gross Profit | 33.0B | 32.0B | 31.5B | 31.2B | 27.2B |
Operating Expenses | 17.9B | 17.7B | 17.0B | 17.0B | 14.6B |
Operating Income | 15.1B | 14.3B | 14.5B | 14.2B | 12.6B |
Pre-tax Income | 10.6B | 9.1B | 9.5B | 8.5B | 2.1B |
Income Tax | 3.2B | 2.2B | 1.9B | 2.4B | 1.9B |
Net Income | 7.4B | 6.9B | 7.6B | 6.1B | 2.2B |
EPS (Diluted) | €2.86 | €2.60 | €2.91 | €2.28 | €0.70 |
Income Statement Trend
Anheuser-Busch InBev Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | 23.0B | 23.4B | 23.2B | 23.9B | 26.5B |
Non-Current Assets | 183.6B | 196.0B | 189.8B | 193.7B | 199.9B |
Total Assets | 206.6B | 219.3B | 212.9B | 217.6B | 226.4B |
Liabilities | |||||
Current Liabilities | 33.1B | 37.2B | 34.4B | 34.2B | 32.4B |
Non-Current Liabilities | 84.9B | 89.5B | 94.3B | 104.1B | 115.7B |
Total Liabilities | 117.9B | 126.7B | 128.7B | 138.3B | 148.1B |
Equity | |||||
Total Shareholders Equity | 88.7B | 92.7B | 84.3B | 79.3B | 78.4B |
Balance Sheet Composition
Anheuser-Busch InBev Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 7.4B | 6.9B | 7.6B | 6.1B | 147.0M |
Operating Cash Flow | 21.7B | 20.4B | 18.0B | 17.6B | 13.1B |
Investing Activities | |||||
Capital Expenditures | -3.7B | -4.5B | -4.8B | -5.5B | -3.7B |
Investing Cash Flow | -3.3B | -4.4B | -4.6B | -5.9B | 6.3B |
Financing Activities | |||||
Dividends Paid | -2.7B | -3.0B | -2.4B | -2.4B | -1.8B |
Financing Cash Flow | -9.9B | -8.6B | -10.6B | -11.6B | -8.5B |
Free Cash Flow | 11.2B | 8.6B | 8.1B | 9.2B | 7.1B |
Cash Flow Trend
Anheuser-Busch InBev Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
21.06
Forward P/E
18.01
Price to Book
1.57
Price to Sales
2.05
PEG Ratio
18.01
Profitability Ratios
Profit Margin
11.75%
Operating Margin
26.46%
Return on Equity
6.60%
Return on Assets
2.83%
Financial Health
Current Ratio
0.70
Debt to Equity
81.53
Beta
0.86
Per Share Data
EPS (TTM)
€2.95
Book Value per Share
€39.61
Revenue per Share
€29.43
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
abi | 120.4B | 21.06 | 1.57 | 6.60% | 11.75% | 81.53 |
Viohalco S.A | 1.4B | 8.66 | 0.73 | 6.81% | 2.80% | 93.48 |
1Spatial Plc | 830.1M | 20.20 | 2.67 | 13.92% | 10.82% | 1.68 |
Candela Invest | 1.8M | 16.22 | 0.76 | -38.06% | -17.47% | 216.99 |
Syneos Health | 6.9B | 377.86 | 1.03 | -1.38% | -1.59% | 28.51 |
Azelis Group NV | 3.2B | 17.86 | 1.12 | 6.77% | 4.29% | 63.15 |
Financial data is updated regularly. All figures are in the company's reporting currency.